You Position: Home > Paper
脓毒症相关凝血功能紊乱的评价与思考
( views:262, downloads:757 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Tuberculosis and Respiratory Diseases
- Issue:
- 9
- DOI:
- 10.3760/cma.j.issn.1001-0939.2018.09.007
- Key Word:
- No keyword available
Abstract： 脓毒症涉及的问题有炎症启动及放大、血管内皮损伤、血小板激活聚集以及凝血因子失衡等,其中炎症和凝血是密不可分的,存在复杂的相互作用,“抗凝还是抗炎”始终是脓毒症抗凝治疗中无法回避的问题.脓毒症患者凝血功能紊乱的走向是疾病发展的重要决定因素,“抗还是不抗?何时开始抗?用什么药物抗?”贯穿于脓毒症抗凝治疗的始终.
- [1]Stevenson,E.K.,Rubenstein,A.R.,Radin,G.T.,etc.Two decades of mortality trends among patients with severe sepsis: A comparative meta-Analysis[J].2014,42(3).
- [2]Levi, Marcel,van der Poll, Tom.Coagulation and sepsis[J].2017,149.
- [3]Seiji, Madoiwa.Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC.[J].2015,3.
- [4]Toshiaki, Iba,Makoto, Arakawa,Jerrold H, Levy,etc.Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin.[J].2018,(Spec ).
- [5]Hiroyasu, Ishikura,Takeshi, Nishida,Akira, Murai,etc.New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study.[J].2014,18(1).
- [6]Ranieri,V.M.,Thompson,B.T.,Barie,P.S.,etc.Drotrecogin alfa (activated) in adults with septic shock[J].2012,366(22).
- [7]Allingstrup, Mikkel,Wetterslev, Jorn,Ravn, Frederikke B.,etc.Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis[J].2016,42(4).
- [8]Yamakawa, K.,Aihara, M.,Ogura, H.,etc.Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis[J].2015,13(4).
- [9]Rhodes, Andrew,Evans, Laura E.,Alhazzani, Waleed,etc.Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016[J].2017,43(3).
- [10]Toshiaki, Iba,Marcello Di, Nisio,Jerrold H, Levy,etc.New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey.[J].2017,7(9).
- [11]Wittebole X,Perrotin D,LaRosa S,etc.Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial.[J].2011,183(11).
- [12]Zarychanski, Ryan,Abou-Setta, Ahmed M.,Kanji, Salmaan,etc.The Efficacy and Safety of Heparin in Patients With Sepsis: A Systematic Review and Metaanalysis[J].2015,43(3).
- [13]Patrick G, Lyons,Scott T, Micek,Nicholas, Hampton,etc.Sepsis-Associated Coagulopathy Severity Predicts Hospital Mortality.[J].2018,(Spec ).
- [14]Changsong, Wang,Chunjie, Chi,Lei, Guo,etc.Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis.[J].2014,18(5).